Want to fulfill your curiosity about the advance made in defence research? Head for the Marine Drive ground where you can take a peek into the technologies, arms, missiles, vehicles, aircraft developed at the laboratories under the Defence Research ... New Indian Express, 11 hours ago
See all (1082) images for "head research"
Aashish Tater, Head of Research, Fortunewizard.com advises to book profit in JM Financial and re-enter in it at lower levels.Money Control, 1 day ago Lupin, Sun Pharma, Dr Reddys Labs safe bets: Tater Money Control, 1 day ago SPARC can give good returns: Aashish Tater Money Control, 1 day ago Market valuations attractive; IT, Pharma and FMCG could be bought: Aditya Birla Money Myiris, 1 month ago
Aashish Tater, Head of Research, Fortunewizard.com advises to exit from TTK Prestige at current levels as there is limited upside in the stock.Money Control, 1 day ago X5 appoints head of soft discounter format MoneyAM, 2 days ago Anant Raj can move to Rs 86: Aashish Tater Money Control, 3 weeks ago Adani Power may slip further: Thununguntla Money Control, 1 month ago
More from: Money Control, Myiris...and 1 other sources
VK Sharma, Head Private Broking Wealth Management at HDFC Securities is of the view that Sun Pharma Advanced Research Company can give better returns than Sun Pharmaceutical Industries.Money Control, 1 day ago
An ex-Ranbaxy Director and Global Head, Research Information & Portfolio Management, Thakur played a key role in providing evidence to the US FDA about the company falsifying data and violating ethical management practices.First Post.com, 3 days ago Ranbaxy whistleblower Thakur richer by Rs 266cr; speaks out Money Control, 4 days ago Ranbaxy whistleblower Thakur to get Rs 266 crore NDTV, 4 days ago Ranbaxy Laboratories 'systematically violated' practices: Whistleblower Dinesh Thakur IndiaTV News, 3 days ago
Paula Brown Stafford, Global Head, Clinical Development, Quintiles, gives an insight about the challenges of clinical research and how it can be addressed May 20 may be an unexceptional date to most, but to those of us within the clinical research ...Express Pharma, 2 days ago Merck Serono, Quintiles sign clinical research deal Bio Spectrum Asia, 2 days ago
Aashish Tater, Head of Research, Fortunewizard.com recommends to invest in Karur Vysya Bank for 25-30 percent returns in one year.Money Control, 2 days ago Buy ING Vysya Bank, says Aashish Tater Money Control, 1 week ago Shift from Axis Bank to ING Vysya Bank: Tater Money Control, 2 weeks ago Expect 30% upside in Dena Bank: Aashish Tater Money Control, 2 months ago
State Bank of Bikaner and Jaipur (SBBJ) has target of Rs 530 over the next 12-15 months, says Aashish Tater, Head of Research, Fortunewizard.com.Money Control, 2 days ago Ramco Industries has target of Rs 68-78: Aashish Tater Money Control, 1 week ago Essel Propack has target of Rs 45-47: Aashish Tater Money Control, 1 month ago Balrampur Chini has target of Rs 70: Aashish Tater Money Control, 1 month ago
Navigation scientist, G. Satheesh Reddy, has been appointed Director of Research Centre Imarat (RCI), a premier missile research laboratory in Hyderabad. An Outstanding Scientist grade with the RCI, Satheesh will formally take over on Wednesday. He joined the ...Business Line, 2 weeks ago New Roche (RHHBY) Award for Antibody-based Cancer Therapy Research BioSpace, 1 day ago New Roche Award for Antibody-based Cancer Therapy Research BioSpace, 2 days ago StanChart appoints Sumit Choudhary as emerging cos research head Business Standard, 3 weeks ago
Bhuvnesh Singh, head of research at Barclays Capital says at Barclays they are overweight on healthcare stocks, some pharma stocks like Sun Lupin. They also like Cairn India and BPCL from the oil and gas sector.Money Control, 4 days ago What stocks you should buy/avoid coming week? Money Control, 2 weeks ago Stock picks for March 7, 2013 One India, 2 months ago Stocks Corner: 4 must-buy pharma stocks Rediff.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!